enVVeno Medical (NVNO) Invested Capital (2017 - 2021)

enVVeno Medical has reported Invested Capital for 3 years, with the latest figure at $41.2 million in Q2 2021.

• On a quarterly basis, Invested Capital rose 6230.29% year-over-year to $41.2 million in Q2 2021; TTM through Jun 2021 was $41.2 million, a 6230.29% increase from a year earlier, with the FY2020 full-year figure at $7.4 million, changed N/A from the prior year.
• Invested Capital was $41.2 million for Q2 2021 at enVVeno Medical, down from $43.3 million in the prior quarter.
• The five-year high for Invested Capital was $43.3 million in Q1 2021, with the low at -$7.8 million in Q4 2017.
• Average Invested Capital over 3 years is $12.9 million, with a median of $5.1 million recorded in 2020.
• The largest YoY upside for Invested Capital was 23282.86% in 2021 against a maximum downside of 6230.29% in 2021.
• Over 3 years, Invested Capital stood at -$7.8 million in 2017, then surged by 195.27% to $7.4 million in 2020, then jumped by 455.77% to $41.2 million in 2021.
• The last three Invested Capital figures came in at $41.2 million (Q2 2021), $43.3 million (Q1 2021), and $7.4 million (Q4 2020), per Business Quant data.